Katrina Megget[email protected]2018Questions, dilemmas abound in fast-moving world of trauma imagingTime is of the essence when it comes to polytrauma, yet numerous questions arise about how and who should be scanned and for which conditions. For a trauma team, making the right imaging decisions for patients with severe injuries can be complex and a matter of life and death. Trauma specialists shared their experiences at today's session at ECR 2018.March 3, 20182018Necessity of gadolinium contrast comes under scrutinyGadolinium-enhanced MRI scans have been the gold standard in suspected cases of vestibular schwannoma and multiple sclerosis (MS), but given the growing evidence of deposits left in the brain, debate has ensued about how to image wisely. Is it always necessary to use gadolinium contrast agents? Regarding vestibular schwannoma and MS, today's Pros and Cons Session will explore this question.March 1, 20182018Safety issues linger over gadolinium-based contrast agentsConclusive research into the safety of gadolinium-based contrast agents could take about a decade to emerge because of the huge difficulties of obtaining enough valuable and objective data. In the meantime, radiologists will be dependent on newly released guidelines from the world's health watchdogs and other reports, ECR 2018 delegates will learn at today's Special Focus Session.February 27, 20182017To be or not to be alarmed over gadolinium contrast? That is the questionThe medical imaging community should be neither alarmed nor develop a gadolinium phobia while waiting for guidance from regulators over controversial gadolinium contrast agents. This is the opinion of Dr. Howard Rowley from the University of Wisconsin in the U.S. and president of the American Society of Neuroradiology.March 2, 20172017Cost-effectiveness, implementation still hinder lung cancer screeningThe public desire for lung cancer screening and the ability of the medical profession to implement it are currently at odds, despite recent findings that suggest screening via low-dose CT can reduce mortality. The problem is lung cancer screening remains controversial and is not as straightforward as most people think, according to Dr. Stefan Diederich, PhD.March 1, 2017Page 1 of 1Top StoriesMRIResting-state fMRI analysis reveals impact of blast exposuresA study of active and veteran U.S. special operations forces cohorts confirms how regions of the brain become altered.MRIMRI radiomics model predicts risk in women with DCISUltrasoundAIUM: Ob/gyn gaining ground on radiology in gynecologic ultrasoundUltrasoundAIUM: POCUS residency tracks improve skills for family med specialistsSponsor ContentElevate your patient's care with the capabilities of Cardiac PET/CT
